v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Total revenue $ 0 $ 212 $ 212 $ 636
Operating expenses:        
Research and development 584 4,143 4,213 15,942
General and administrative 2,839 2,994 13,808 11,346
Total operating expenses 3,423 7,137 18,021 27,288
Loss from operations (3,423) (6,925) (17,809) (26,652)
Other income (expense):        
Termination fee 0 0 50,000 0
Interest income 778 462 1,893 1,629
Gain on sale of joint venture and other income (expense) 0 22,479 (18) 22,771
Total other income, net 778 22,941 51,875 24,400
(Loss) income before income tax and equity in losses of joint venture (2,645) 16,016 34,066 (2,252)
Income tax expense 80 0 1,404 0
Loss on investment in joint venture 0 0 0 874
Net (loss) income $ (2,725) $ 16,016 $ 32,662 $ (3,126)
Net (loss) income per common share, basic (in dollars per share) $ (0.48) $ 2.84 $ 5.73 $ (0.56)
Net (loss) income per common share, diluted (in dollars per share) $ (0.48) $ 2.84 $ 5.64 $ (0.56)
Weighted-average common shares outstanding, basic (in shares) 5,715,048 5,632,291 5,701,011 5,611,536
Weighted-average common shares outstanding, diluted (in shares) 5,715,048 5,632,291 5,788,752 5,611,536
Other comprehensive (loss) gain:        
Net unrealized gain (loss) on marketable securities $ 0 $ 7 $ (18) $ (44)
Other comprehensive gain (loss) 0 7 (18) (44)
Comprehensive (loss) gain (2,725) 16,023 32,644 (3,170)
Collaboration and license revenue        
Revenue:        
Total revenue $ 0 $ 212 $ 212 $ 636